Treatment of Liver Hemangioma in Kasabach-Merritt Syndrome, Giant or Growing Hepatic Haemangioma, or Symptomatic Compression

This protocol addresses hepatic haemangioma presenting in one of the following high-risk situations: Kasabach-Merritt syndrome, a giant hepatic haemangioma, a growing hepatic haemangioma, or a haemangioma causing symptoms through compression of adjacent structures.

These presentations are uncommon. Affected individuals should be referred to a benign liver tumour multidisciplinary team for evaluation and management planning.

In select complicated or unresectable cases, a major surgical procedure targeting the liver itself may be considered as part of management. The full protocol specifies the clinical criteria, patient selection pathway, and decision algorithm.

Complete eligibility criteria, clinical decision steps, and the full management pathway are available in the structured protocol below.